ALIGN TECHNOLOGY INC

NASDAQ: ALGN (Align Technology, Inc.)

Last update: 20 hours ago

166.20

5.69 (3.54%)

Previous Close 160.51
Open 163.74
Volume 1,275,514
Avg. Volume (3M) 945,613
Market Cap 12,231,920,640
Price / Earnings (TTM) 29.57
Price / Earnings (Forward) 20.58
Price / Sales 3.88
Price / Book 4.01
52 Weeks Range
158.13 (-4%) — 335.40 (101%)
Earnings Date 30 Apr 2025
Profit Margin 10.54%
Operating Margin (TTM) 18.18%
Diluted EPS (TTM) 5.62
Quarterly Revenue Growth (YOY) 4.00%
Quarterly Earnings Growth (YOY) -16.30%
Total Debt/Equity (MRQ) 2.29%
Current Ratio (MRQ) 1.22
Operating Cash Flow (TTM) 738.23 M
Levered Free Cash Flow (TTM) 622.33 M
Return on Assets (TTM) 6.87%
Return on Equity (TTM) 11.26%

Market Trend

Short Term Medium Term
Industry Medical Instruments & Supplies (US) Mixed Mixed
Medical Instruments & Supplies (Global) Mixed Mixed
Stock Align Technology, Inc. Bearish Bearish

AIStockmoo Score

2.0
Analyst Consensus 3.0
Insider Activity NA
Price Volatility 5.0
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average 2.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ALGN 12 B - 29.57 4.01
COO 16 B - 39.24 1.91
HOLX 14 B - 19.21 3.04
ISRG 202 B - 88.49 11.25
RGEN 9 B - - 22.02
MMSI 6 B - 47.83 4.20

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Sector Healthcare
Industry Medical Instruments & Supplies
Investment Style Mid Core
% Held by Insiders 6.83%
% Held by Institutions 89.64%
855.50855.50689.00689.00522.50522.50356.00356.00189.50189.50Median Price TargetQ2 '20Q2 '20Q3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25
52 Weeks Range
158.13 (-4%) — 335.40 (101%)
Price Target Range
255.00 (53%) — 280.00 (68%)
High 280.00 (Leerink Partners, 68.47%) Buy
Median 265.00 (59.45%)
Low 255.00 (Wells Fargo, 53.43%) Buy
Average 266.17 (60.15%)
Total 6 Buy
Avg. Price @ Call 219.28
Firm Date Target Price Call Price @ Call
Wells Fargo 14 Feb 2025 255.00 (53.43%) Buy 206.77
Evercore ISI Group 06 Feb 2025 260.00 (56.44%) Buy 218.38
Morgan Stanley 06 Feb 2025 272.00 (63.66%) Buy 218.38
Piper Sandler 06 Feb 2025 270.00 (62.45%) Buy 218.38
Jefferies 23 Jan 2025 260.00 (56.44%) Buy 234.89
Leerink Partners 06 Jan 2025 280.00 (68.47%) Buy 218.88

No data within this time range.

205.09205.09188.02188.02170.94170.94153.86153.86136.78136.78Mar 5Mar 5Mar 6Mar 6Mar 7Mar 7Mar 10Mar 10Mar 11Mar 11Mar 12Mar 12Mar 13Mar 13Mar 14Mar 14

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

10010075755050252500RSI (14D)
5.0005.0000.0000.000-5.000-5.000-10.000-10.000-15.000-15.000MACD (12, 26, 9)

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria